Talk:Neostigmine

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Neostigmine.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

errata in lippincott's 3rd and 4th edition on duration of action

Duration of action of neostigmine is incorrectly described as 30 minutes to 2 hours on page 51 of Lippincott's Pharmacology. However, on page 53 of the SAME text, it says 2 to 4 hours. Other Pharmacology texts, including Brenner's Pharmacology 3rd Ed. say neostigmine has a duration of action of 2-4 hours. —Preceding unsigned comment added by 70.160.229.8 (talk) 11:13, 5 February 2011 (UTC) Neostigmine is NOT a reversible inhibitor of AChE, it is a pseudo-irreversible inhibitor like all carbamate inhibitors. 86.161.229.240 (talk) 23:01, 7 February 2014 (UTC)PJ Jewess[reply]

could be just a "pseudo errata"

CLinical duration of action of neostigmine is related to dose and way of administration. Oral intake (used in miastenia gravis) can produce hours of clinical efect, but IV dose can produce half to one hour of clinical efect. --Gmutizabal (talk) 02:50, 9 May 2012 (UTC)[reply]